ID   240E1-1-2
AC   CVCL_J972
SY   240E 1-1-2; 240E-1-1-2
DR   Wikidata; Q54583501
RX   Patent=US5675063;
RX   PubMed=7568130;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11870.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
DI   NCIt; C133738; Rabbit plasmacytoma
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_J971 ! 240E1-1
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 11
CH   CVCL_Z068 ! 240E-W
CH   CVCL_N033 ! 80-1
CH   CVCL_J969 ! 99S6
CH   CVCL_J970 ! 99S9
//
RX   PubMed=7568130; DOI=10.1073/pnas.92.20.9348; PMCID=PMC40982;
RA   Spieker-Polet, Helga
RA   Sethupathi, Periannan
RA   Yam, Pi-Chen
RA   Knight, Katherine L.
RT   "Rabbit monoclonal antibodies: generating a fusion partner to produce
RT   rabbit-rabbit hybridomas.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:9348-9352(1995).
//
RX   Patent=US5675063;
RA   Knight, Katherine L.
RT   "Immortalized rabbit hybridoma fusion partner.";
RL   Patent number US5675063, 07-Oct-1997.
//